Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers - another member of the aspartic acid-rich protein superfamily

Author： Fuselier H.A.   Moore K.   Lindberg J.   Husserl F.E.   Cole F.E.   Kok D.J.   Whitehead D.   Galliano D.J.   Erwin D.T.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.52, Iss.6, 1998-12, pp. : 988-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary tamm-horsfall protein increased after potassium citrate therapy in calcium stone formers

By Fuselier H.A.   Ward D.M.   Lindberg J.S.   Allen J.M.   Husserl F.E.   Marcucci P.A.   Cole F.E.   Turnipseed J.   Alam J.   Kok D.J.   Erwin D.T.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 942-946

Elsevier

Access to resources Recommend Favorite

Long-term Follow-up of Stone Formers Treated with a Low Dose of Sodium Potassium Citrate

By Jendle-Bengten Cecilia   Tiselius Hans-Göran  

Scandinavian Journal of Urology and Nephrology, Vol. 34, Iss. 1, 2000-02 ,pp. : 36-41

Informa Healthcare

Access to resources Recommend Favorite

Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients - citrate inhibition depends on macromolecules larger than 30 kilodalton

By Ganter K.   Bongartz D.   Hesse A.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 492-495

Elsevier

Access to resources Recommend Favorite

Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers

By Asokan D.  

Urological Research, Vol. 32, Iss. 5, 2004-10 ,pp. : 357-361

Springer Publishing Company

Access to resources Recommend Favorite

Effect of verapamil on urinary stone-forming risk factors

By Sarica Kemal  

Urological Research, Vol. 35, Iss. 1, 2007-02 ,pp. : 23-27

Springer Publishing Company

Access to resources Recommend Favorite